Circulating MicroRNAs as stable blood-based markers for cancer
Monday, 8 December 2008- Dr. Muneesh Tewari from Fred Hutchinson Cancer Center at the University of Washington concluded that MIR-141 is a cancer-associated microRNA. He shared his research results on the characterisation of this microRNA and the development of a miR-141 based diagnostic test to identify prostate...
Edited by: JV
Temperature-enhanced metastatic therapy for prostate cancer
Friday, 5 December 2008 - Lead investigator Prof. Robert Getzenberg, urology and molecular science professor at the Johns Hopkins University in Baltimore, Maryland (USA), discussed his preliminary findings on temperature-enhanced metastatic therapy for prostate cancer during the Prostate Cancer Foundation (PCF) 15th...
Edited by: JV
Continent urinary reconstruction is an optimal method in treatment of invasive bladder cancer
Thursday, 4 December 2008 - Continent urinary reconstruction is an optimal method in treatment of invasive bladder cancer, stated Z.Y. Zirel et al during the EAU 2nd North Eastern European Meeting 2008 in Vilnius. The results of their study have shown that this series complications rate is acceptable and comparable to...
Edited by: FGR
Additional immune checkpoints in prostate cancer: PD-1 and LAG-3
Wednesday, 3 December 2008 - At the Prostate Cancer Foundation (PCF) 15th Annual Scientific Retreat held at Incline Village, Nevada, USA, Dr. Charles Drake from Johns Hopkins presented new information on immune checkpoints that may present additional therapeutic opportunities.
According to Drake,...
Edited by: JV
Trans obturator tape proves similar efficacy as TVT procedure
Wednesday, 3 December 2008 - Trans obturator tape (TOT) seems to be a safe and effective method of treatment of the stress urinary incontinence in the short follow up, even in women that had ineffective earlier operative treatments of the incontinence. As Polish urologists Mikulska-Jovanovic M. et al. stated at the...
Edited by: FGR
Circulating prostate tumour cells and Micro Electronic Machines
Tuesday, 2 December 2008 - At the Prostate Cancef Foundation (PCF) 15th Annual Scientific Retreat held at Incline Village, Nevada, USA, Dr. Daniel Haver and Mehmet Toner of the Massachusetts General Hospital Cancer Center discussed new approaches to detecting circulating tumour cells.
Haber and Toner have...
Edited by: JV
Future prospects in cancer genome research
Monday, 1 December 2008 - Complete sequencing of the three billion genetic letters in the genome of a cancer patient will soon be a practical reality. At the recent Prostate Cancer Foundation (PCF) 15th Annual Scientific Retreat held at Incline Village, Nevada, USA, Dr. Todd Golub discussed current studies...
Edited by: JV
Prostate-cancer-targeted nanoparticles study to spur new treatment strategies
Friday, 28 November 2008- Prostate-cancer-targeted nanoparticles loaded with anti-tumour drugs like taxotere are among the awaited new treatment strategies that can deliver far higher drug doses to tumour cells without compromising healthy cells, according to US investigators.
This was part of the key findings...
Edited by: JV
Genes linked with fat metabolism could increase kidney cancer risk
Thursday, 27 November 2008 - A team of international scientists has identified three genes associated with the body's processing of fats that may increase kidney cancer risk. The findings were presented at the American Association for Cancer Research's 7th Annual International Conference on Frontiers in Cancer...
Edited by: JV
PSA serum evaluation for prostate cancer screening makes no sense in industrial areas
Wednesday, 26 November 2008 - At the EAU 4th South Eastern European Meeting held in Albania, D. Galiopoulos, T. Lambou, et al. did not find current evidence supporting the usefulness of PSA serum evaluation for the screening of PC in Greece. Even in regions with environmental pollution PSA serum evaluation does...
Edited by: FGR
